JP Morgan Chase’s OncoSec Medical Incorporated ONCS Stock Holding History

JP Morgan Chase’s Portfolio ONCS Stock Details ONCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Hold	0	–	–	–	6192
2020 Q3	–	Hold	0	–	–	–	6041
2020 Q2	–	Hold	0	–	–	–	5956
2020 Q1	–	Hold	0	–	–	–	5986
2019 Q4	–	Sell	-5,076	Closed	-$220K	–	6108
2019 Q3	$220K	Buy	5,076 +4,254	+518%	+$200K	﹤0.01%	4594
2019 Q2	$46K	Buy	+822	New	+$79.1K	﹤0.01%	5205
2018 Q2	–	Sell	-227	Closed	-$94K	–	5807
2018 Q1	$94K	Buy	+227	New	+$93.1K	﹤0.01%	4608
2017 Q4	–	Sell	-3	Closed	-$1K	–	5681
2017 Q3	$1K	Hold	3	–	–	﹤0.01%	4934
2017 Q2	$1K	Hold	3	–	–	﹤0.01%	4910
2017 Q1	$1K	Hold	3	–	–	﹤0.01%	5009
2016 Q4	$1K	Hold	3	–	–	﹤0.01%	4976
2016 Q3	$1K	Hold	3	–	–	﹤0.01%	4488
2016 Q2	$1K	Hold	3	–	–	﹤0.01%	4722
2016 Q1	$2K	Buy	+3	New	+$1.28K	﹤0.01%	4531

Other funds holding ONCS

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SFP

Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return

JP Morgan Chase's ONCS Position: Q4 2020 in Review

JP Morgan Chase held its OncoSec Medical Incorporated (ONCS) position steady in Q4 2020 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #6192.

JP Morgan Chase first reported a position in ONCS in Q1 2016 and has held it in 10 quarters since. The position peaked at $220K in Q3 2019. 31 funds tracked by Wall St. Rank hold ONCS as of Q4 2020.

JP Morgan Chase held 0 shares of OncoSec Medical Incorporated worth $0 as of Q4 2020.
JP Morgan Chase left its OncoSec Medical Incorporated share count unchanged in Q4 2020.
OncoSec Medical Incorporated made up ﹤0.01% of JP Morgan Chase's portfolio in Q4 2020, its #6192 holding.
JP Morgan Chase first reported a position in OncoSec Medical Incorporated in Q1 2016 and has held it in 10 quarters since.
JP Morgan Chase's OncoSec Medical Incorporated position peaked at $220K in Q3 2019.
31 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2020.

Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.